Presentation NY Valves 2024 Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications? Presenter: Brian K. Whisenant June 07, 2024
Presentation NY Valves 2024 Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough? Presenter: Susheel K. Kodali June 07, 2024
Presentation NY Valves 2024 The Compelling Case for Transcatheter Tricuspid Therapies Presenter: Philipp Lurz June 07, 2024
Presentation NY Valves 2024 Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States Presenter: Tsuyoshi Kaneko June 07, 2024
Presentation NY Valves 2024 The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities Presenter: Helge Möllmann June 07, 2024
Presentation NY Valves 2024 Ongoing Research Clinical Research – Impact on Future Guidelines? Presenter: Dimosthenis Pandis June 07, 2024
Presentation NY Valves 2024 Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients Presenter: Nino Mihatov June 07, 2024
Presentation NY Valves 2024 Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement Presenter: Jörg Hausleiter June 07, 2024
Presentation NY Valves 2024 What Is the Future of Percutaneous Tricuspid Valve Procedures? Presenter: Eric Horlick June 07, 2024
Presentation NY Valves 2024 The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities Presenter: Bassem M. Chehab June 07, 2024